Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

GENE

Genetic Technologies (GENE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GENE
DataOraFonteTitoloSimboloCompagnia
12/12/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
23/09/202414:30GlobeNewswire Inc.Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2NASDAQ:GENEGenetic Technologies Ltd
11/09/202414:15GlobeNewswire Inc.Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 ClinicsNASDAQ:GENEGenetic Technologies Ltd
15/08/202414:00GlobeNewswire Inc.Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platformNASDAQ:GENEGenetic Technologies Ltd
09/08/202414:00GlobeNewswire Inc.Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15NASDAQ:GENEGenetic Technologies Ltd
26/07/202414:00GlobeNewswire Inc.Genetic Technologies Strategic Restructure Driving USA Sales GrowthNASDAQ:GENEGenetic Technologies Ltd
16/07/202414:00GlobeNewswire Inc.Genetic Technologies Announces Appointment of Chief Financial Officer & Company SecretaryNASDAQ:GENEGenetic Technologies Ltd
09/07/202414:00GlobeNewswire Inc.GeneType to Enter Canadian and New Zealand MarketsNASDAQ:GENEGenetic Technologies Ltd
25/06/202414:00GlobeNewswire Inc.GeneType Identifies 79.5% of People Tested are at Risk of Serious DiseaseNASDAQ:GENEGenetic Technologies Ltd
21/06/202414:00GlobeNewswire Inc.Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27NASDAQ:GENEGenetic Technologies Ltd
18/06/202414:00GlobeNewswire Inc.Genetic Technologies Expands Operational Capacity in North AmericaNASDAQ:GENEGenetic Technologies Ltd
05/06/202414:00GlobeNewswire Inc.GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk TestNASDAQ:GENEGenetic Technologies Ltd
29/05/202414:00GlobeNewswire Inc.GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian CancerNASDAQ:GENEGenetic Technologies Ltd
28/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
23/05/202414:00GlobeNewswire Inc.GeneType and Humanise Health host “Know Your Risk” EventNASDAQ:GENEGenetic Technologies Ltd
06/05/202414:00GlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
22/04/202421:00GlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
18/04/202418:17GlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
17/04/202414:00GlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
16/04/202414:00GlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
11/04/202414:00GlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
08/04/202414:00GlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
02/04/202414:05GlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
26/03/202413:00GlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
25/03/202413:00GlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
14/02/202420:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
31/01/202414:00GlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
05/01/202414:00GlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
20/12/202323:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
14/12/202314:00GlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GENE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network